Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
AMRI Albany Molecular Research Inc
AXPW Axion Power International Inc
OCFN Omega Commercial Finance Corp
IEP Icahn Enterprises LP
BIDU Baidu Inc
GOOGL Alphabet Inc
MSFT Microsoft Corp
BRK.B Berkshire Hathaway Inc
AAPL Apple Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company operates in one segment: the development of pharmaceutical products on its own behalf or in collaboration with others. The Company, through its platform technologies, targets a range of diseases and disorders through RNA-targeted mechanisms of action. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases. The Company's lead Duchenne Muscular Dystrophy (DMD) product candidate, Eteplirsen, is an antisense phosphorodiamidate morpholino oligomer (PMO) therapeutic in Phase III clinical development for the treatment of individuals with DMD having an error in the gene coding for dystrophin that is amenable to skipping exon 51.

Price
Delayed
$22.59
Day's Change
-0.7601 (-3.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
24.28
Day's Low
21.85
Volume
(Heavy Day)

Today's volume of 7,185,405 shares is on pace to be much greater than SRPT's 10-day average volume of 5,627,679 shares.

7,185,405
  • Prev Close
    23.35
  • Today's Open
    23.18
  • Day's Range
    21.85-24.28
  • Avg Vol (10-day)
    5.6M
  • Last (time)
    2:04p ET 05/26/16
  • Last (size)
    750
  • 52-Wk Range
    8.00 - 41.97
    LowHigh
  • (10/05/15 - 04/26/16)
    182.37%
  • 137.5%
  • Market Cap
    1.0B
  • Shares Outstanding
    45.8M
  • -5.01
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 74.76
  • (% of float 05/15/16)
    53.70

Latest News

Yesterday's News, May 25, 2016
2:53 pm ET
MarketWatch
12:35 pm ET
Zacks
9:46 am ET
MarketWatch
9:24 am ET
MarketWatch
7:00 am ET
BusinessWire
May 20, 2016
4:00 pm ET
Globe Newswire
May 10, 2016
5:08 pm ET
BusinessWire
May 06, 2016
12:19 pm ET
BusinessWire
May 05, 2016
7:00 am ET
BusinessWire
May 03, 2016
9:10 am ET
Zacks
May 02, 2016
1:05 pm ET
Zacks
April 28, 2016
9:41 am ET
MarketWatch
9:11 am ET
MarketWatch
8:45 am ET
MarketWatch
8:30 am ET
Zacks
April 27, 2016
3:07 pm ET
Zacks
7:20 am ET
MarketWatch
April 26, 2016
11:36 am ET
Zacks
8:50 am ET
MarketWatch
8:50 am ET
MarketWatch
8:49 am ET
MarketWatch
8:49 am ET
MarketWatch
8:48 am ET
MarketWatch
8:02 am ET
MarketWatch
7:53 am ET
MarketWatch
7:53 am ET
MarketWatch
7:52 am ET
MarketWatch
7:51 am ET
MarketWatch
7:18 am ET
MarketWatch
April 25, 2016
10:58 pm ET
BusinessWire
7:05 am ET
MarketWatch
April 24, 2016
8:25 pm ET
PR Newswire
April 21, 2016
2:26 pm ET
Zacks
April 20, 2016
3:38 pm ET
Zacks
April 07, 2016
10:30 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.